Background illustration for clinical trials search

Paid Clinical Trials Toronto

Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

for
Follicular Lymphoma
Location: Toronto, Towson MD, Fredericksburg VA, Roanoke VA,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06911502

Phase 3, Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Toronto, Hamilton, Buffalo NY, Rochester NY, London,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase 3, Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Toronto, Ottawa, Pittsburgh PA, Hershey PA, Montreal,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase 3, Recruiting

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

for
Malignant Neoplasm
Location: Toronto, Montreal, Columbus OH, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06979596

Phase 2, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Toronto, Oshawa, Barrie, Greater Sudbury, Ottawa,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06966700

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Toronto, Barrie, London, Windsor, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase 3, Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: Toronto, Pittsburgh PA, York PA, Winchester VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase 3, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Toronto, Detroit MI, Pittsburgh PA, Montreal,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

for
CRC (Colorectal Cancer)
Location: Toronto, Pittsburgh PA, Ann Arbor MI, Morgantown WV,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07284849

Phase 3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Toronto, Oshawa, Mentor OH, Orange OH, Cleveland OH,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase 3, Recruiting

Rehab Study for alloBMT Patients

for
Allogenic Bone Marrow Transplantation
Location: Toronto
Sponsor: Jennifer Jones

Sex: All

Age: 18+

Code: NCT07457866

Recruiting

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Toronto, Pittsburgh PA, Montreal, Columbus OH,
Sponsor: AVEO Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06064877

Phase 3, Recruiting

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

for
Breast Cancer, Colorectal Cancer, Pancreas Cancer,
Location: Toronto, Kingston
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05403177

Recruiting

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

for
Breast Cancer, Melanoma, Gastrointestinal Neuroendocrine Tumor
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05196087

Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for
Myelofibrosis
Location: Toronto, Hamilton, Ann Arbor MI, Montreal, Columbus OH,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase 1, Phase 2, Recruiting

Durvalumab and Oleclumab in Resectable PDAC

for
Pancreatic Ductal Adenocarcinoma
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06060405

Phase 2, Recruiting

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

for
Advanced Hepatocellular Carcinoma
Location: Toronto, Chicago IL, Charlotte NC, Dallas TX, Miami FL,
Sponsor: Iterion Therapeutics

Sex: All

Age: 18+

Code: NCT05797805

Phase 1, Phase 2, Recruiting

Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer

for
Prostate Cancer
Location: Toronto, London
Sponsor: University Health Network, Toronto

Sex: Male

Age: 18+

Code: NCT05328505

Recruiting

StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias

for
Cardiac Arrhythmia
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04843683

Recruiting

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: Toronto, Columbus OH, Hackensack NJ, New York NY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT04973605

Phase 1, Phase 2, Recruiting